The next treatments of chronic kidney disease: If we find them, can we test them?

被引:13
作者
Hostetter, TH [1 ]
机构
[1] NIDDKD, NIH, Bethesda, MD 20892 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷 / 12期
关键词
D O I
10.1097/01.ASN.0000042343.03375.1B
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3024 / 3026
页数:3
相关论文
共 14 条
[1]   Add-on angiotensin receptor blockade with maximized ACE inhibition [J].
Agarwal, R .
KIDNEY INTERNATIONAL, 2001, 59 (06) :2282-2289
[2]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[3]  
Buckalew V, 2002, DIABETES, V51, pA38
[4]   Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. [J].
Chrysostomou, A ;
Becker, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :925-926
[5]   Aldosterone in progressive renal disease [J].
Hostetter, TH ;
Rosenberg, ME ;
Ibrahim, HN ;
Juknevicius, I .
SEMINARS IN NEPHROLOGY, 2001, 21 (06) :573-579
[6]   Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data [J].
Jafar, TH ;
Schmid, CH ;
Landa, M ;
Giatras, I ;
Toto, R ;
Remuzzi, G ;
Maschio, G ;
Brenner, BM ;
Kamper, A ;
Zucchelli, P ;
Becker, G ;
Himmelmann, A ;
Bannister, K ;
Landais, P ;
Shahinfar, S ;
de Jong, PE ;
de Zeeuw, D ;
Lau, J ;
Levey, AS .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (02) :73-87
[7]  
Keane WF, 2002, J AM SOC NEPHROL, V13, p249A
[8]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[9]   THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].
LEWIS, EJ ;
HUNSICKER, LG ;
BAIN, RP ;
ROHDE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462
[10]   Pentoxifylline attenuated the renal disease progression in rats with remnant kidney [J].
Lin, SL ;
Chen, YM ;
Chien, CT ;
Chiang, WC ;
Tsai, CC ;
Tsai, TJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (12) :2916-2929